Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: a randomized phase 2 trial. | Crit Rev Oncol Hematol;64(1): 64-72, 2007 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: a randomized phase 2 trial.

Romieu, G; Clemens, M; Mahlberg, R; Fargeot, P; Constenla, M; Schütte, M; Easton, V; Skacel, T; Bacon, P; Brugger, W.

Affiliation

Romieu G; CRLC Val d'Aurelle, Montpellier, France.

Crit Rev Oncol Hematol ; 64(1): 64-72, 2007 Oct.

Article in En | MEDLINE | ID: mdl-17317205

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Granulocyte Colony-Stimulating Factor / Neutropenia Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: Crit Rev Oncol Hematol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2007 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Granulocyte Colony-Stimulating Factor / Neutropenia Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Female / Humans Language: En Journal: Crit Rev Oncol Hematol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2007 Document type: Article Affiliation country: